ROLE OF SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN VOIDING DYSFUNCTION

@article{Christmas1988ROLEOS,
  title={ROLE OF SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN VOIDING DYSFUNCTION},
  author={Timothy J. Christmas and Christopher R. Chapple and Andrew John Lees and P. A. Kempster and J. P. Frankel and Gerald M. Stern and E. J. G. Milroy},
  journal={The Lancet},
  year={1988},
  volume={332},
  pages={1451-1453}
}
Ten patients with Parkinson's disease and urinary symptoms underwent urodynamic assessments before and after subcutaneous administration of the dopamine receptor agonist apomorphine. Voiding efficiency improved after apomorphine injection, with an increase in mean and maximum flow rates in nine patients and reduction in post-micturition residual volume in six. Although the effect on detrusor behaviour was variable, subcutaneous apomorphine may be of use in both the assessment and treatment of… Expand
Defecatory function in Parkinson's disease: Response to apomorphine
TLDR
It is concluded that apomorphine can correct anorectal dysfunction in PD, and that these abnormalities may be a consequence of dopamine deficiency secondary to the PD process. Expand
Effects of apomorphine and L‐dopa on the parkinsonian bladder
TLDR
The results confirm the role of dopaminergic lesions in the occurrence of bladder hyperreflexia and the possible implication of nondopaminergic patients in the occurrences of hyporeflexia. Expand
of Parkinson ' s disease . Subcutaneous apomorphine in the treatment
a median period of 16 months. In 30 given intermittent suprathreshold injections the mean number of hours spent in a disabling off state fell from 6-9 to 2-9. Similar benefit was observed in 21Expand
The role of subcutaneous infusion of apomorphine in Parkinson’s disease
TLDR
The evidence regarding efficacy, safety and tolerability of CSAI is summarized, guidance on the selection of suitable patients and practical instructions on how to initiate and manage possible adverse events are given. Expand
Urinary dysfunction in Parkinson's disease: a review.
TLDR
The presentation of, pathophysiology behind and management options for bladder dysfunction in IPD are discussed. Expand
Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson's disease
TLDR
Doxazosin resulted in the improvement of lower urinary tract symptoms and the maximum flow rate and was well tolerated in men with Parkinson's disease. Expand
Assessment and Treatment of Urinary Incontinence in Neurologically Impaired Patients
This chapter is mainly concerned with the neurogenic bladder dysfunction in multiple sclerosis (MS), following a cerebrovascular accident (CVA) and in idiopathic Parkinsons’ disease (IPD). In recentExpand
Subcutaneous apomorphine in the treatment of Parkinson's disease.
TLDR
Subcutaneous apomorphine is proposed as an effective treatment for patients with incapacitating "off" period disabilities refractory to oral medication and should be considered before experimental implantation procedures. Expand
Pathophysiology of bladder dysfunction in Parkinson's disease
TLDR
Anticholinergic agents are used to treat bladder dysfunction in PD, although these drugs should be used with caution particularly in elderly patients who have cognitive decline, which might help in maximizing the patients' quality of life. Expand
Evaluation of vesico-urethral and sweating function in disorders presenting with parkinsonism
TLDR
Although there are differences in vesico-urethral and sweating function, they do not precisely differentiate between patients with classical Parkinson's disease and those with parkinsonism associated with features suggestive of more extensive involvement of the nervous system. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 14 REFERENCES
Micturition disturbance in Parkinson's disease.
TLDR
It was concluded that micturition difficulty in the patient with IPD is due to detrusor hyperreflexia, influenced by the basal ganglia, which is not associated with impaired striated urethral sphincter activity. Expand
Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon?
TLDR
The dysfunctional pattern of muscle recruitment resembled that characteristic of dystonia elsewhere in the body and was indistinguishable in patients with idiopathic anismus and those with extrapyramidal motor disturbance due to Parkinson's disease, suggesting that anismu may be a focal dystonic phenomenon. Expand
Neurourologic findings in Parkinson's disease.
TLDR
A total of 30 patients with an established diagnosis of Parkinson's disease and symptomatic voiding dysfunction underwent neurourologic evaluation and it was assumed that the effect of the basal ganglia on micturition is inhibitory in nature. Expand
Neurogenic bladder in parkinsonism: effect of thalamotomy.
TLDR
In a group of 62 patients with Parkinsonism, 44 had significant bladder dysfunction, although only one had acute urinary retention, and forty-nine patients underwent one or more stereotaxic thalamotomies. Expand
THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRACEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSON'S DISEASE
Apomorphine in combination with a peripheral dopamine receptor blocker (domeperidone) was administered to four parkinsonian patients in a double-blind placebo-controlled study. The therapeuticExpand
Urethral sphincter abnormalities in Parkinsonism.
TLDR
Urethral sphincter function was studied in 14 patients with Parkinsonism, but profound abnormalities were present in four patients who had markedly increased spHincter tone and sp hincter tremor and who failed to relax the sphiffer when voiding. Expand
SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONS
TLDR
Results confirm that during off periods dopamine receptors remain responsive to stimulation and provide evidence of a new, effective, and well-tolerated treatment for the most disabling complication of long-term levodopa therapy. Expand
Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control.
TLDR
It is concluded that the major risk of incontinence following prostatectomy in the parkinsonian patient is associated with lack of voluntary sphincter control. Expand
Extrapyramidal inhibition of the urinary bladder.
Abstract Inhibition of spontaneous (‘reflex’, ‘micturition’) contractions of the urinary bladder by electrical stimulation of anterior brain stem structures functionally related to the extrapyramidalExpand
Fluctuations of disability in Parkinson's disease – clinical aspects
Publisher Summary This chapter discusses that Parkinson's disease, although in most respects a chronic, progressive disorder, can also be seen as a paroxysmal condition. Sudden, extreme, andExpand
...
1
2
...